emilpharma 
Dealstreet

ELP acts on Somerset Indus Capital Partners' investment in Emil Pharmaceutical

The deal amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Emil Pharmaceutical Industries Pvt Ltd, a pharmaceutical contract development and manufacturing organization. This marks the fund’s fifth overall and second pharmaceutical investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this deal.

The transaction team consisted of Vinay Butani (Partner), Taskeen Hamid (Counsel) and Vinit Shah (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Trial set to begin in Savarkar defamation case after Rahul Gandhi formally pleads 'not guilty'

One Nation One Election Bill not unconstitutional but needs work: Former CJI Chandrachud tells JPC

Beyond the hype: AI disruption in India’s legal practice

Kerala consumer court orders myG Future to pay over ₹15,000 for false discount claim on biriyani pot

Trilegal, Khaitan act on Ashok Goel Trust investment in Bambrew

SCROLL FOR NEXT